Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis - PowerPoint PPT Presentation

About This Presentation
Title:

Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis

Description:

The Multiple Sclerosis Therapeutics Market was valued at US$ 24,026.90 million in 2019 and it is projected to reach US$ 39,223.59 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027. – PowerPoint PPT presentation

Number of Views:2
Slides: 9
Provided by: pradnya_tip
Tags:

less

Transcript and Presenter's Notes

Title: Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis


1
Multiple Sclerosis Therapeutics Market Forecast
To 2027
Published Date Feb 2021
Email sales_at_theinsightpartners.com
2
Multiple Sclerosis Therapeutics Market Valuation

Email sales_at_theinsightpartners.com
50,000





40,000
30,000
CAGR of 6.5
20,000
(2020 - 2027)
10,000
0
20XX
20XX
20XX
20XX
20XX
3
Report Studies
Email sales_at_theinsightpartners.com
  • Multiple Sclerosis Therapeutics Market Forecast
    to 2027 - COVID-19 Impact and Global Analysis By
    Drug Class (Immunosuppressant and
    Immunomodulators), Route of Administration
    (Injectable and Oral), and Distribution Channel
    (Hospital Pharmacies, Retail Pharmacies, and
    E-Commerce), and Geography

4
Multiple Sclerosis Therapeutics Market Overview
Email sales_at_theinsightpartners.com
  • The Multiple Sclerosis Therapeutics Market was
    valued at US 24,026.90 million in 2019 and it is
    projected to reach US 39,223.59 million by 2027
    it is expected to grow at a CAGR of 6.5 from
    2020 to 2027.
  • Based on drug class, the market is segmented into
    immunosuppressant and immunomodulators. In 2019,
    the immunomodulators segment accounted for larger
    share of the market. Growth of this segment is
    attributed to launch of new generic drugs and
    increase in adoption of immunomodulators in
    multiple sclerosis (MS) treatment. The
    immunosuppressant segment is likely to register
    higher CAGR during the forecast period.

5
Company Profiles
Email sales_at_theinsightpartners.com
  • Merck Co., Inc.
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Bristol-Myers Squibb Company
  • Horizon Therapeutics plc.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Takeda Pharmaceutical Company Limited
  • F. HOFFMANN-LA ROCHE LTD.
  • Biogen

Download Sample Here
6
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

Download Sample Here
7
7
For More Detailed Information Visit
  • https//www.theinsightpartners.com/reports/microca
    theters-market

Download Sample Here
8
THANK YOU!
Phone 1-646-491-9876
E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com